M
0.200
0.00 (-2.44%)
| Previous Close | 0.205 |
| Open | 0.200 |
| Volume | 326,100 |
| Avg. Volume (3M) | 343,728 |
| Market Cap | 195,781,008 |
| Price / Earnings (Forward) | 33.33 |
| Price / Sales | 4.02 |
| Price / Book | 2.58 |
| 52 Weeks Range | |
| TTM Dividend Yield | 2.00% |
| Profit Margin | 6.52% |
| Operating Margin (TTM) | 7.02% |
| Quarterly Revenue Growth (YOY) | -9.20% |
| Quarterly Earnings Growth (YOY) | -82.70% |
| Total Debt/Equity (MRQ) | 20.42% |
| Current Ratio (MRQ) | 10.75 |
| Operating Cash Flow (TTM) | 6.88 M |
| Levered Free Cash Flow (TTM) | 4.15 M |
| Return on Assets (TTM) | 6.31% |
| Return on Equity (TTM) | 5.47% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (MY) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | METRO | - | - |
AIStockmoo Score
-0.2
| Analyst Consensus | 0.0 |
| Insider Activity | 3.0 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.0 |
| Average | -0.20 |
|
Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
| % Held by Insiders | 69.24% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| DR TAY SWI PENG @ TEE SWI PENG | 0.205 | - | 40,000 | 8,200 |
| Aggregate Net Quantity | 40,000 | |||
| Aggregate Net Value ($) | 8,200 | |||
| Aggregate Avg. Buy ($) | 0.205 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| DR TAY SWI PENG @ TEE SWI PENG | Director | 09 Jun 2025 | Acquired (+) | 20,000 | 0.205 | 4,100 |
| DR TAY SWI PENG @ TEE SWI PENG | Substantial Shareholder | 09 Jun 2025 | Acquired (+) | 20,000 | 0.205 | 4,100 |
| TTM Dividend Yield | 2.00% |
| Payout Ratio | 114.89% |
| Expected Next Dividend Payment | Apr 2026 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 10 Apr 2025 | 21 Mar 2025 | 22 Apr 2025 | 0.004 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2025 | 0.004 | 1 | 2.00 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |